EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor‐β‐mediated growth inhibition in hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|7|929-937

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.7, 2015-07, pp. : 929-937

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirtuin 6 promotes transforming growth factor‐β1/H2O2/HOCl‐mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 559-566

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β‐dependent manner in human osteosarcoma

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1394-1401

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transforming growth factor‐β signaling enhancement by long‐term exposure to hypoxia in a tumor microenvironment composed of Lewis lung carcinoma cells

By  

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1524-1533

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epithelial–mesenchymal transition is regulated at post‐transcriptional levels by transforming growth factor‐β signaling during tumor progression

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 481-488

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma

By  

Cancer Science, Vol. 106, Iss. 8, 2015-08 ,pp. : 1016-1022

John Wiley & Sons Inc

Access to resources Recommend Favorite